The track of supplementing iron raw materials continues to heat up: Market dynamics and future prospects of ferrous fumarate
Ferrous fumarate, as an organic iron nutrient enhancer and a raw material for pharmaceutical iron supplementation, is widely used in the three major fields of medicine, feed, and food due to its high iron content, good stability, and outstanding cost-effectiveness. At present, China is the world's major producer and consumer of ferrous fumarate, with the highest proportion of feed additives in the downstream structure and leading the growth rate in the pharmaceutical industry.
The demand side is showing multiple driving forces: in terms of medicine, the population with iron deficiency anemia has a large base, and pregnant women, children, and the elderly continue to drive demand. Ferrous fumarate tablets/granules are the base drug and a Class A medical insurance product, while generic drugs are steadily increasing in quantity; In terms of feed, the scale of aquaculture and the policy of reducing and banning antibiotics promote the substitution of inorganic iron with organic iron. Ferrous fumarate has a high absorption rate and does not damage vitamins, becoming the mainstream choice; In terms of food, the demand for nutritional supplements such as infant and toddler food, nutrition packs, infant formula, and grains continues to grow.
Policies will be upgraded synchronously with the industrial sector. The stricter supervision of environmental protection and safety, the increased control of three wastes in the chemical industry, and the gradual optimization of some small and medium-sized production capacity are beneficial for leading enterprises that operate in a standardized manner. The Chinese Pharmacopoeia and quality standards have raised requirements for purity, heavy metals, and residual impurities, promoting the upgrading of the industry's quality. At the same time, feed and food regulations encourage the use of organic trace elements, and the export environment benefits from tariff preferences such as RCEP, which remains positive. Jiayuan Biotechnology Company stated, "We have observed that the market for ferrous fumarate is upgrading from ordinary feed grade to pharmaceutical grade, food grade, and high-purity grade. The market recognition of high-purity products continues to increase, and the company is accelerating process optimization and capacity layout to meet downstream high-end demand." Industry analysis suggests that the future growth core of ferrous fumarate will come from pharmaceutical and high-end feed demand. Green technology, high-end products, and compound formulations (such as ferrous fumarate+VC/folic acid/B12) are expected to become the long-term main focus. Meanwhile, fluctuations in upstream raw material prices and competition in low-end product prices remain factors that the industry needs to pay attention to. Overall, the concentration of industries is expected to continue to increase, and standardized top enterprises are expected to gain more market opportunities.

CN
EN


